Latest Breaking News On - Sharon bio - Page 1 : vimarsana.com

Innova Captab makes flat start at Rs 456 against IPO price of Rs 448

The Rs 570-crore public issue of pharmaceutical company had received good response from investors with a subscription of 55.26 times during December 21-26. Qualified institutional buyers (QIBs) bought 116.73 times the portion set aside for them

Jammu and kashmirHong kongSharon bioAjanta pharmaGlenmark pharmaceuticalsIntas pharmaceuticalsEmcure pharmaceuticalsHimachal pradesh basedIndoco remediesZuventus healthcareSharon bio medicineInnova captab ipoInnova captab ipo gmpInnova captab ipo listing dateNnova captab ipo listing priceNnova captab ipo listing price prediction

Will Innova Captab see double-digit gains on debut?

Innova Captab is set to debut on the bourses on December 29. This is going to be the last mainboard listing for the current calendar year

Prathamesh masdekarManoj kumar lohariwalaSaral sethAjanta pharmaSharon bioIntas pharmaceuticalsEmcure pharmaceuticalsGlenmark pharmaceuticalsInnova captabHimachal pradesh basedAzad engineeringIndoco remediesZuventus healthcareIndsec securitiesVinay kumar lohariwala promotedBankruptcy code

IPO: Innova Captab may be a good buy after a post-listing review

The promoters Manoj Kumar Lohariwala and his brother Vinay Kumar Lohariwala are diluting their stakes from 67% to 52%. Of the issue proceeds, ₹168 crore would be used toward debt repayment and ₹72 crore for working capital requirements.

Sri lankaVinay kumar lohariwalaManoj kumar lohariwalaSharon bioIntelligence groupHarun health careInnova captabSharon bio medicineGrowth prospectsAdding sharonWindlas biotechWorking capital

Innova Captab IPO: Should you subscribe to the Rs 570-crore issue?

Innova Captab IPO: Ahead of the debut, the pharmaceutical company mobilised Rs 171 crore from several anchor investors

Jammu and kashmirHimachal pradeshSharon bioAshoka whiteoak emerging marketsAditya birla sun life insurance companyCanara robeco mutual fundBandhan mutual fundMorgan stanleyPrudential mutual fundLife insurance companyInnova captabSharon bio medicineCopthall mauritius investmentMutual fundKotak mahindra trusteeAshoka whiteoak emerging markets trust

Cyril Amarchand Mangaldas advises on CIRP of Sharon Bio-Medicine

Cyril Amarchand Mangaldas advises on CIRP of Sharon Bio-Medicine
newkerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newkerala.com Daily Mail and Mail on Sunday newspapers.

New delhiNeha shivhareSrideepa bhattacharyyaSharon bioAnush mathkarMadhav kanoriaCyril amarchand mangaldasJeta shreeNayani agarwalSurbhi pareekJayesh karnawatPulkit guptaHonble supreme courtUniventis medicareInnova captabHonble national company law tribunal